Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs 是一家专注于人工智能药物发现的平台，成立于2021年，源自谷歌的 DeepMind。近日，该公司 首次 获得外部融资，共计6亿美元轮融资由 Thrive Capital 领投，参与者包括 GV 和现有投资者 ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

你知道吗？人工智能正在快速改变制药行业，呼唤着新的药物研发方式。最近，英国的Isomorphic Labs宣布融资6亿美元，这不仅是为了提升其AI药物设计引擎的速度，更是为了向AI攻克疾病的宏伟目标迈出一步。

Investing.com — Alphabet Inc.旗下利用人工智能 (AI)进行药物发现的公司Isomorphic Labs已获得6亿美元的融资。这是该公司首次获得外部资金。 此轮融资由Thrive ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

财联社3月31日电，Alphabet的子公司IsomorphicLabs当地时间3月31日宣布已在其首轮外部融资中筹集到6亿美元。本轮融资由ThriveCapital领投，GV和现有投资者Alphabet跟投… ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...